

See product citations (37)
QUICK LINKS
RO-3306 may act to inhibit CDK1/cyclin B1 and CDK1/cyclin A. It also inhibits CDK2 (Ki = 340 nM), PKCδ (Ki = 318 nM), and serum- and glucocorticoid-induce kinase (Ki = 497 nM) but not CDK4.1. It reversibly arrests human cells at the G2/M border of the cell cycle and allows for effective cell synchronization without the use of microtubule poisons in early mitosis. Prolonged treatment of cells with RO-3306 induces apoptosis and this can be augmented in acute myeloid leukemia cells by stimulating p53 activity with nutlin-3.3. In other words, RO-3306 actively enhances downstream p53 signaling to promote apoptosis.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RO-3306, 1 mg | sc-358700 | 1 mg | $66.00 | |||
RO-3306, 5 mg | sc-358700A | 5 mg | $163.00 | |||
RO-3306, 25 mg | sc-358700B | 25 mg | $326.00 |